Category: Policy

FDA on Advances Medical Product Innovation

From FDAs Blog: FDA Advances Medical Product Innovation Posted onMarch 17, 2015byFDA Voice By: Margaret A. Hamburg, M.D. On March 10, I had the pleasure of appearing with my colleagueDr. Francis Collinsbefore theSenate Committee on Health, Education, Labor and Pensionsto testify at a hearing on the subject of Continuing Americas Leadership in Medical Innovation for […]

Health Policy: This Week in Washington

This Week in Washington: Obama and Pence are in Washington today: Obama rallying Obamacare, to defend as much of it as possible and Pence to discuss specifics of the transition period with Republicans. Democrats are messaging #ProtectOurCare Republican Study Committee plans to announce theirreplacementplan this afternoon: The American Health Care Reform Act of 2017. Republicans […]

Wealth Shouldn’t be a Requirement for Health

Without insulin, many people with diabetes (PWDs) would die. Its not a luxury item; its a necessity. Endocrinologist Dr. Silvio Inzucchi estimates in someone with 0% insulin production, theyll begin to fall ill within 12-24 hours after last insulin injection, depending on its duration of effectand mortal outcomes would likely occur within days to perhaps […]

The issue: UnitedHealthcare insulin pump restrictions

As a community, we are committed to enhancing the lives of all individuals living with diabetes, which necessitates easy access to therapies and technologies. Making the healthy choice the easy choice is a key part of success with this condition and payers and governments can play an enabling role in that quest by following these […]

NCCIH presents “When Experts Disagree: The Art of Medical Decision Making”

What The National Center for Complementary and Integrative Health (NCCIH) will welcome acclaimed authors Jerome Groopman, M.D. and Pamela Hartzband, M.D. as featured speakers for the sixth annual Stephen E. Straus Distinguished Lecture in the Science of Complementary Health Therapies. The husband-and-wife team will present When Experts Disagree: The Art of Medical Decision Making. Dr. […]

Newt Gingrich: Double the N.I.H. Budget: NYT

In an op-ed piece in the New York Times the conservative former Speaker of the House calls for doubling the investment in NIH funding. ( In part he says: Unfortunately, since the end of the five-year effort that roughly doubled the N.I.H. budget by 2003, funding for the institutes has been flat. The N.I.H. budget […]

An Example of Diabetes Advocacy: Senate Finance Committee

Alyra Donisvitch, type 1 patient, testified about access to a pump as part of a hearing on medical device taxes. Her testimony is offered here example of clear, not overly emotionaltestimony of a patient with diabetes. If you want to watch see video 32:25 to 36:50 at A Fresh Look at the Impact of the […]

Regulations and Policies for School Diabetes Care by State

Federal law gives students the right to receive the diabetes care they need to be safe and participate in school activities just like any other child.Some states give more protections, or give helpful guidance on how to best provide diabetes care in the school setting. Learn about your federal and states laws and resources here: […]

Providing Timely Patient Access to High

Jeffrey Shuren, M.D., J.D. We know that patients with life-threatening or irreversibly debilitating conditions lack treatment and diagnostic options. For these patients, earlier access to promising new devices is critically important. At the same time, delayed access may mean the difference between life and death, or may result in irreversible disability. In weighing the benefits […]

DHF Joins Diabetes Advocacy Alliance

SourceDHF Blog: Diabetes Hands Foundation is incredibly honored to join theDiabetes Advocacy Alliance, an organization with the drive and potential to affect a powerful, positive impact on diabetes and healthcare policy. Diabetes Advocacy Alliance is a 20-member coalition of leading professional societies, nonprofit organizations, and policy change-makers from across the national diabetes landscape. Included among […]